Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Abroad (travel likely)Recruiting

Conditions

Urothelial Carcinoma (UC) · Bladder (Urothelial, Transitional Cell) Cancer · Liquid Biopsy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The second hospital of Tianjin Medical University, Tianjin, China
Contact: Study coordinator (Hailong Hu) · huhailong@tmu.edu.cn · +8613662096232

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NSCLC Adenocarcinoma · Gastroesophageal Cancer (GC) · Gastric Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1

Santa Rosa, United States · Washington D.C., United States

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Urothelial Carcinoma (UC) · Upper Tract Urothelial Carcinoma · UTUC

Abroad (travel likely)Recruiting

Zhengzhou, China

Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer

Bladder Cancer · Urothelial Carcinoma (UC) · Hematuria

Abroad (travel likely)Recruiting

Oceanside, United States · San Diego, United States

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Urothelial Carcinoma (UC)

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China